scientific-superintelligence
(2)
Geoffrey von Maltzahn
Geoffrey von Maltzahn is the co-founder and CEO of Lila Sciences, a Cambridge company building what it calls scientific superintelligence: AI plus robotic labs that run the scientific method autonomously. A general partner at Flagship Pioneering, he has founded or co-founded a string of companies including Generate:Biomedicines, Tessera Therapeutics, Indigo Agriculture, Sana Biotechnology, Seres Therapeutics and Quotient Therapeutics, which together carry more than $10 billion in market value. He holds a PhD from the Harvard-MIT Division of Health Sciences and Technology and is named on more than 200 patents.
Jack Milwid
Jack Milwid is a scientist-turned-company-builder who sits in the Office of the CEO at Lila Sciences, the Flagship Pioneering venture chasing 'scientific superintelligence' through autonomous AI-run laboratories. A materials engineer with a Harvard-MIT PhD, he has spent his career founding biotech companies from scratch - among them Sana Biotechnology, Neon Therapeutics, Cobalt Biomedicine and Kaleido Biosciences - and co-founded the investment firm Related Sciences. His trademark is turning early science into operating companies.